Skip to main content
  • On-demand Webinar

2022 Outlook and Updates for the US Food and Drug Administration

Review recently released and expected guidance documents from the US FDA, the growing use of real-world evidence and regulatory science tools in submissions, and expectations for 2022 and beyond.

United States Capitol building

Watch now: 2022 outlook and updates for the US Food and Drug Administration

Regulatory expectations around the world continue to change with time and experience, and the US FDA provides significant guidance on their expectations. This webinar reviews recently released and expected guidance documents, the growing use of real-world evidence and regulatory science tools in submissions, and expectations for 2022 and beyond.  

Webinar date 

March 10, 2022

Speaker

Sarah Fitzgerald, RAC, senior consultant, Quality and Regulatory Affairs, Emergo by UL

 

This webinar will help you gain a better understanding of the current state of the US FDA and key forces shaping the medical device market today.

Learning objectives:
  • New and updated guidance documents that are expected to be published in 2022
  • Using real-world evidence and regulatory science tools to bring products to market
About the presenter:

Sarah Fitzgerald, RAC, senior consultant, Quality and Regulatory Affairs, Emergo by UL

Sarah Fitzgerald has 15 years of experience in medical device regulatory and quality affairs, including supporting products from concept to end-of-life, regulatory strategy and submissions, including more than 20 pre-market submissions to the FDA and six Emergency Use authorization (EUA) submissions. She is the US Regulatory Program Manager and a senior consultant, Quality and Regulatory Affairs at Emergo.

 

Attend an upcoming webinar

Ready to elevate your industry IQ with insights and news from experts? Register for one of our upcoming events.

View upcoming webinars